Stocks Health care SILO

NASDAQ · Health care

Silo Pharma, Inc. (SILO)

It posted a net loss of $4.5M. At June 30, 2026 it held $3.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

What Silo Pharma, Inc. does

Silo Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SILO.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where SILO ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Silo Pharma, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 19, 2026
   Material agreement 8-K
2. August 17, 2026
   Bylaws or fiscal year changed 8-K
3. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.76 versus -$2.88.
4. August 13, 2026
   Passive stake changed SCHEDULE 13G/A
5. August 6, 2026
   Securities offering prospectus 424B3
6. July 31, 2026
   Employee stock plan registration S-8
7. July 24, 2026
   Shelf registration to sell securities S-3
8. July 13, 2026
   Material agreement 8-K
9. July 8, 2026
   Passive stake (5% or more) SCHEDULE 13G
10. June 30, 2026
    Annual report to shareholders ARS

Recent insider filings (Forms 3, 4 and 144): 10, the latest on December 16, 2025. Insider transactions on SEC

Who owns SILO

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Anson Funds Management LP 4.9% (February 17, 2026); SEG Opportunity Fund, LLC 0% (February 13, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SILO

What does Silo Pharma, Inc. do?

Silo Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SILO.

Is Silo Pharma, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $4.5M.

When did Silo Pharma, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from August 19, 2026.

Similar companies

Compare SILO with

Compare SILO with any company

Follow SILO

Get an email when Silo Pharma, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SILO: get an email when it files

Where the numbers come from

Financial figures are the values Silo Pharma, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.